Cancer News and Research

Latest Cancer News and Research

Physicians may soon have new tool to closely track severity, potential spread of metastatic melanoma

Physicians may soon have new tool to closely track severity, potential spread of metastatic melanoma

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

Cancer concerns over chromium diet pills

Cancer concerns over chromium diet pills

Cholesterol-lowering drug simvastatin could become effective treatment for Parkinson's

Cholesterol-lowering drug simvastatin could become effective treatment for Parkinson's

New approach to package dual or more mixtures into a single capsule may boost drug efficiency

New approach to package dual or more mixtures into a single capsule may boost drug efficiency

Common painkiller diclofenac has significant anti-cancer properties

Common painkiller diclofenac has significant anti-cancer properties

Excess folic acid intake causes lowered immune function in aged mice

Excess folic acid intake causes lowered immune function in aged mice

Scientists discover protein interaction that describes aggressive subtype of medulloblastoma

Scientists discover protein interaction that describes aggressive subtype of medulloblastoma

Researchers use quick screening method to identify, test promising anti-Ebola drugs

Researchers use quick screening method to identify, test promising anti-Ebola drugs

MD Anderson signs collaborative research and development agreement with Enumeral

MD Anderson signs collaborative research and development agreement with Enumeral

McMaster University researchers take a giant leap in detecting early stages of leukemia

McMaster University researchers take a giant leap in detecting early stages of leukemia

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

Docetaxel remains effective in prostate cancer even after treatment with androgen-deprivation therapy

Sorrento, Karolinska Institutet partner to develop new NK cell-based therapies

Sorrento, Karolinska Institutet partner to develop new NK cell-based therapies

Wistar Institute scientists use revolutionary method to block melanoma progression

Wistar Institute scientists use revolutionary method to block melanoma progression

American College of Cardiology to honor LA BioMed researcher with Distinguished Teacher Award

American College of Cardiology to honor LA BioMed researcher with Distinguished Teacher Award

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

F-star signs agreement with AbbVie to discover, develop bispecific antibodies in immuno-oncology

Breast cancer patients only moderately informed about pros and cons of breast reconstructive surgery

Breast cancer patients only moderately informed about pros and cons of breast reconstructive surgery

New strategy may reduce growth of pancreatic cancers in patients with KRAS gene mutation

New strategy may reduce growth of pancreatic cancers in patients with KRAS gene mutation

European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

European clinicians to discuss broadcasts of latest research presented at 2016 Genitourinary Cancers Symposium

DNA-binding protein acts like genetic traffic signal to orchestrate early stage embryonic development

DNA-binding protein acts like genetic traffic signal to orchestrate early stage embryonic development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.